Your browser doesn't support javascript.
loading
Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
Mato, Anthony R; Nabhan, Chadi; Barr, Paul M; Ujjani, Chaitra S; Hill, Brian T; Lamanna, Nicole; Skarbnik, Alan P; Howlett, Christina; Pu, Jeffrey J; Sehgal, Alison R; Strelec, Lauren E; Vandegrift, Alexandra; Fitzpatrick, Danielle M; Zent, Clive S; Feldman, Tatyana; Goy, Andre; Claxton, David F; Bachow, Spencer Henick; Kaur, Gurbakhash; Svoboda, Jakub; Nasta, Sunita Dwivedy; Porter, David; Landsburg, Daniel J; Schuster, Stephen J; Cheson, Bruce D; Kiselev, Pavel; Evens, Andrew M.
Afiliación
  • Mato AR; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Nabhan C; University of Chicago Comprehensive Cancer Center, Chicago, IL.
  • Barr PM; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Ujjani CS; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Hill BT; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
  • Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
  • Skarbnik AP; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Howlett C; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Pu JJ; Penn State Cancer Institute, Penn State University, Hershey, PA.
  • Sehgal AR; University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, PA.
  • Strelec LE; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Vandegrift A; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Fitzpatrick DM; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Zent CS; Wilmot Cancer Institute, University of Rochester, Rochester, NY.
  • Feldman T; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Claxton DF; Penn State Cancer Institute, Penn State University, Hershey, PA.
  • Bachow SH; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
  • Kaur G; Tufts University Medical Center, Boston, MA; and.
  • Svoboda J; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Nasta SD; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Porter D; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Landsburg DJ; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Schuster SJ; Center for Chronic Lymphocytic Leukemia, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
  • Cheson BD; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.
  • Kiselev P; Celgene Corporation, Summit, NJ.
  • Evens AM; Tufts University Medical Center, Boston, MA; and.
Blood ; 128(18): 2199-2205, 2016 11 03.
Article en En | MEDLINE | ID: mdl-27601462
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Purinas / Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Quinazolinonas / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article País de afiliación: Panamá
Buscar en Google
Banco de datos: MEDLINE Asunto principal: Purinas / Pirazoles / Pirimidinas / Leucemia Linfocítica Crónica de Células B / Quinazolinonas / Antineoplásicos Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2016 Tipo del documento: Article País de afiliación: Panamá